bismilda-v 1

1. Prevalence of Beijing Central Asian/Russian Cluster 94-32 among Multidrug-Resistant M. tuberculosis in Kazakhstan
2. USE OF 15 MIRU-VNTR GENOTYPING FOR DISCRIMINATING M. TUBERCULOSIS CLINICAL ISOLATES FROM KAZAKHSTAN
3. Comparative Analysis of 2 Diagnostic Devices for Detection of Mycobacterium tuberculosis and Drug Resistance in Almaty, Kazakhstan, to Determine the Optimal Diagnostic for Local Needs
4. Rates and risk factors of monoresistance against isoniazid and multidrug-resistant tuberculosis in Almaty, Kazakhstan
5. Genomic Analysis of Multidrug-Resistant Mycobacterium tuberculosis Strains From Patients in Kazakhstan
6. Whole-Genome Sequence-Based Characterization of Pre-XDR M. tuberculosis Clinical Isolates Collected in Kazakhstan
7. β-Aminopropioamidoximes derivatives as potential antitubercular agents against anthropozoonotic infections caused by Mycobacterium tuberculosis and Mycobacterium bovis
8. Boulton-katritzky rearrangement of 5-substituted phenyl-3-[2-(Morpholin-1-yl)ethyl]-1,2,4-oxadiazoles as a synthetic path to spiropyrazoline benzoates and chloride with antitubercular properties
9. Genetic diversity, drug resistance, and transmission patterns of tuberculosis based on whole-genome sequencing in Almaty, Kazakhstan
1